Wright Medical Group N.V

Wright Medical — Tornier — Investor Presentation (January 2013)

26 slides from Wright Medical's investor presentation, Jan 7, 2013

  1. Slide 1: David Mowry, Interim President and CEO

    January 7, 2012 David Mowry, Interim President and CEO Specialists SERVING Specialists Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements Statements contained in this presentation that relate to future, not past, events are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations of future events and often can be ident

  3. Slide 3: Non-GAAP Financial Measures

    Non-GAAP Financial Measures Tornier uses certain non-GAAP financial measures in this presentation, such as constant currency. Tornier uses non-GAAP financial measures as supplemental measures of performance and believes these measures provide useful information to investors in evaluating Tornier’s o

  4. Slide 4: Global Medical Device Company, Focusing on Surgeons Treating Extremities Injuries and Disorders

    Global Medical Device Company, Focusing on Surgeons Treating Extremities Injuries and Disorders Specialists SERVING Specialists EXTREMITIES

  5. Slide 5: The Tornier Story: Positioning for Future Growth

    The Tornier Story: Positioning for Future Growth BROADEST PRODUCT PORTFOLIO HIGH GROWTH MARKET SCALE FOR EFFICIENT SALES Extremities Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science & Education Robust Drivers Assure Growth $6.5B 7-9% CAGR (’12 – ’17) Targe

  6. Slide 6: Attractive Market for Extremities

    Attractive Market for Extremities BROADEST PRODUCT PORTFOLIO SCALE FOR EFFICIENT SALES HIGH GROWTH MARKET Extremities Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science Education Target High-Volume Extremities Specialists EXECUTION FOCUS FOR 2013 Robust Driv

  7. Slide 7: Large and Growing Global Extremities Market

    Large and Growing Global Extremities Market 8-9% CAGR UPPER EXTREMITES 7-8% CAGR SPORTS MEDICINE & BIOLOGICS 7-8% CAGR LOWER EXTREMITIES $2.7B ~ $4.0B $2.1B ~ $3.0B $1.7B ~ $2.5B Total Extremities Market Is $6.5B with 7-9% CAGR 2012 2017 2012 2017 2012 2017

  8. Slide 8: Robust Extremities Market Drivers Provide Opportunity for Future Growth and Differentiation

    Robust Extremities Market Drivers Provide Opportunity for Future Growth and Differentiation Active, Younger Patient Population Expanding Knowledge of Treatment Options Early Stages of Device Innovation Opportunity for Material and Design Improvements TECHNOLOGY PATIENTS OUTCOMES Upside for Continued

  9. Slide 9: 2012 Actions Focused on Capturing Opportunities

    2012 Actions Focused on Capturing Opportunities ACTIONS OPPORTUNITY 1 2 3 ACTIONS OPPORTUNITY Specific Press-fit Shoulder Broaden Lower Extremities Offering US SALES CHANNEL EXECUTION OVERHEAD / EXPENSE REDUCTION Access to Foot & Ankle Sales Channel New Sales Management Organization Developed 2013 P

  10. Slide 10: OrthoHelix Acquisition: Complementary Capabilities

    OrthoHelix Acquisition: Complementary Capabilities PRODUCTS Broad Shoulder Portfolio Elbow Arthroplasty Strong Ankle Arthroplasty Sports Medicine & Biologics Foot & Ankle Fixation Comprehensive Upper & Lower Extremities Portfolio with Minimal Overlap GEOGRAPHY US Europe Emerging Markets US Only Chan

  11. Slide 11: Filling Out Our Extremities Product Portfolio

    Filling Out Our Extremities Product Portfolio SCALE FOR EFFICIENT SALES HIGH GROWTH MARKET BROADEST PRODUCT PORTFOLIO Target High-Volume Extremities Specialists Robust Drivers Assure Growth Extremities $6.5B EXECUTION FOCUS FOR 2013 BROADEST PRODUCT PORTFOLIO Upper Extremities Lower Extremities Biol

  12. Slide 12: Portfolio Strategy Leverages Strong Arthroplasty Position

    Portfolio Strategy Leverages Strong Arthroplasty Position #2 Top 5 #1 JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE $1.2B $6.5B CALL POINT FOCUS JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE SHOULDER HAND, WRIST AND ELBOW FOOT AND ANKLE PROCEDURES LEVERAGE Strength of Products

  13. Slide 13: Most Comprehensive Extremities Product Portfolio

    13 12 10 2 3 35 9 Most Comprehensive Extremities Product Portfolio 4 JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE CALL POINT FOCUS 88 Distinct Extremities Products JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE SHOULDER HAND, WRIST AND ELBOW FOOT AND ANKLE PROCEDURES

  14. Slide 14: Filling Out Portfolio with High-Impact New Products

    Filling Out Portfolio with High-Impact New Products UPPER EXTREMITIES LOWER EXTREMITIES January ‘13 UPPER EXTREMITIES Shoulder Arthroplasty % of Addressed Procedures ADDED Ascend Flex Press-Fit Reverse Shoulder (Revision Friendly) LOWER EXTREMITIES Foot and Ankle Procedures % of Addressable Procedur

  15. Slide 15: Tornier Shoulder Portfolio: Building a Continuum of Care

    Anatomic Reverse Convertible Tornier Shoulder Portfolio: Building a Continuum of Care Varying Treatment Anchors Fracture Resurfacing Stemless Revision CTA Glenoid Conservative to More Aggressive Treatments PyC Ascend Flex Options

  16. Slide 16: The “Go-To” Company for the Specialist

    The “Go-To” Company for the Specialist RESPECTED FOR SCIENTIFIC RIGOR CLINICAL DATA DRIVEN STRATEGY Aequalis Shoulder Registry Simpliciti Shoulder US IDE Study Salto-Talaris Total Ankle Data Set Pyrolytic Carbon Material & Application Biologic Augmentation Synthetic Growth Factors Significant Invest

  17. Slide 17: Efficient, Targeted Sales Distribution

    Efficient, Targeted Sales Distribution BROADEST PRODUCT PORTFOLIO HIGH GROWTH MARKET SCALE FOR EFFICIENT SALES Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science Education Robust Drivers Assure Growth Extremities $6.5B 7-9% CAGR (’202 – 2017) EXECUTION FOCUS

  18. Slide 18: US: Planning for Focused Upper and Lower Sales Distribution

    US: Planning for Focused Upper and Lower Sales Distribution Scale Drives Flexibility CHANNEL FOCUS MIRRORS CUSTOMER SPECIALIZATION Upper Extremities Lower Extremities Sales Force: Surgeon Specialists: Shoulder, Elbow, Wrist & Hand Foot and Ankle Complete Offering / Procedure Coverage Product Pull-th

  19. Slide 19: International: Addressing Mature and Underpenetrated Markets

    International: Addressing Mature and Underpenetrated Markets OUS Launch of OrthoHelix Products in 2H ‘13 MATURE MARKETS – Focused Extremities Channels – Japan Converted to Direct 2Q12 – Belgium Converted to Direct in 3Q12 – Canada Conversion Planned for 1H13 UNDER PENETRATED MARKETS – Underpenetrate

  20. Slide 20: The Outlook for 2013

    The Outlook for 2013 BROADEST PRODUCT PORTFOLIO SCALE FOR EFFICIENT SALES HIGH GROWTH MARKET Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science Education Target High-Volume Extremities Specialists Upper Extremities Lower Extremities Robust Drivers Assure Gro

  21. Slide 21: Energized, Execution-Focused Leadership Team

    POSITION EXPERIENCE Energized, Execution-Focused Leadership Team POSITION EXPERIENCE Dave Mowry Interim President & CEO Shawn McCormick CFO Terry Rich SVP US Commercial Ops David Andersen VP Global Marketing Robert Ball VP Global R & D Stéphan Epinette VP International Commercial Ops Kevin Klemz VP,

  22. Slide 22: Positioning the Company for Future Growth

    Positioning the Company for Future Growth TECHNOLOGY LEADER DRIVE REVENUE DRIVE REVENUE INCREASE GROWTH RATE Continue to Innovate Across Portfolio 10 – 12 New Products Per Year Increase the Focus of Our Sales Channels Balanced Global Extremities Growth Direct in Mature Markets; Expand in Emerging Ma

  23. Slide 23: 2013 – We Will Focus on a Vital Few Initiatives

    2013 – We Will Focus on a Vital Few Initiatives 1 2 3 US Sales Channel Alignment OrthoHelix Integration New Product Launches

  24. Slide 24: Positioned for Growth: Revenue

    Positioned for Growth: Revenue HISTORY GEOGRAPHY $75.8-78.8M* US ~56% OUS ~44% * Expected 2012 revenue as reiterated in press release on January 7, 2013 HISTORY GEOGRAPHY $201M $227M $261M $274 - 277M* 2009 2010 2011 Expected 2012 $274 - $277M Expected 2012*

  25. Slide 25: Summary

    Summary BROADEST PRODUCT PORTFOLIO HIGH GROWTH MARKET Extremities SCALE FOR EFFICIENT SALES BROADEST PRODUCT PORTFOLIO Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science & Education HIGH GROWTH MARKET Robust Drivers Assure Growth $6.5B 7-9% CAGR (’12 – ’17)

  26. Slide 26: Specialists SERVING Specialists

    Specialists SERVING Specialists

Tornier — Investor Presentation (January 2013) on 6ix